Exelon Forecast, price target & analysts
Exelon Target price 2026 - Analyst rating & recommendation
Exelon Classifications & Recommendation
Exelon Price Target
| Target Price | $48.96 |
| Price | $42.60 |
| Potential | 14.93% |
| Number of Estimates | 20 |
| 20 Analysts have issued a price target Exelon 2027 . The average Exelon target price is $48.96. This is 14.93% higher than the current stock price. The highest price target is $60.90 42.96% , the lowest is $41.41 2.79% . | |
| A rating was issued by 26 analysts: 7 Analysts recommend Exelon to buy, 17 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Exelon stock has an average upside potential 2027 of 14.93% . Most analysts recommend the Exelon stock at Hold. |
Sales and Margin forecast 2026, 2027 to 2030
20 Analysts have issued a sales forecast Exelon 2026 . The average Exelon sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
16 Analysts have issued an Exelon EBITDA forecast 2026. The average Exelon EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
22 Exelon Analysts have issued a net profit forecast 2026. The average Exelon net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
Current Exelon Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Argus Research |
Buy
➜
Buy
|
Unchanged | Sep 22 2026 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Sep 18 2026 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Aug 21 2026 |
| Truist Securities |
Hold
➜
Hold
|
Unchanged | Aug 13 2026 |
| Truist Securities |
Hold
➜
Hold
|
Unchanged | Jul 16 2026 |
| Truist Securities |
Hold
➜
Hold
|
Unchanged | May 29 2026 |
| TD Cowen |
Hold
➜
Hold
|
Unchanged | May 15 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Argus Research:
Buy
➜
Buy
|
Sep 22 2026 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Sep 18 2026 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Aug 21 2026 |
|
Unchanged
Truist Securities:
Hold
➜
Hold
|
Aug 13 2026 |
|
Unchanged
Truist Securities:
Hold
➜
Hold
|
Jul 16 2026 |
|
Unchanged
Truist Securities:
Hold
➜
Hold
|
May 29 2026 |
|
Unchanged
TD Cowen:
Hold
➜
Hold
|
May 15 2026 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
